NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email The private credit industry is facing fresh scrutiny from top global regulators over some of the ratings being assigned to debt in the $1.7 trillion market, people familiar with the matter told Bloomberg News.Read More